Back to results
US 2014/0037584 A1Published application
Oncolytic rhabdovirus
AssigneeChildren's Hospital of Eastern Ontario Research Institute Inc.
InventorDavid F. STOJDL
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention include compositions and methods related to non-VSV rhabdoviruses and their use as anti-cancer therapeutics. Such rhabdoviruses possess tumor cell killing properties in vitro and in vivo.
Claims20
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an oncolytic Farmington rhabdovirus.
A method for treating cancer in a subject comprising administering to the subject an effective amount of an oncolytic Faimington rhabdovirus.
Dependencies are inferred from the claim text.